[1] Camacho PM, Petak SM, Binkley N,et al.American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis - 2016. Endocr Pract. 2016;22(Suppl 4):1-42.
[2] Eastell R, O’Neill TW, Hofbauer L, Cet al.Postmenopausal Osteoporosis. Nat Rev Dis Primers. 2016;2:16069.
[3] 李微,张博,张雨薇,等.雌激素调节骨代谢作用的研究进展[J].中国骨质疏松杂志,2017,23(2):262-266.
[4] Wright NC, Looker AC, Saag KG, et al. The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based On Bone Mineral Density at the Femoral Neck Or Lumbar Spine. J Bone Miner Res. 2014;29(11):2520-2526.
[5] Wu M, Chen G, Li YP. TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and Disease. Bone Res. 2016;4:16009.
[6] 柴爽,王吉利,黄佳纯,等. 补肾健脾活血方对去卵巢大鼠 BMP2/Smad 信号通路的影响[J].中国实验方剂学杂志,2018,24(20): 129-133.
[7] 柴爽.去卵巢大鼠骨组织mRNA和lncRNA表达特征及中药的干预作用[D].广州:广州中医药大学,2019.
[8] 刘少津.补肾健脾活血方对去卵巢大鼠BMP2/Smad信号通路的影响[D].广州:广州中医药大学,2019.
[9] 万雷,黄宏兴,蔡桦,等.补肾健脾活血方对老年女性骨质疏松患者疼痛和血清β-CTx、N-MID、T-PINP 的影响[J].辽宁中医杂志, 2015,42(9):1690-1692.
[10] 中国老年学和老年医学学会骨质疏松分会肌肉、骨骼与骨质疏松学科组.肌肉、骨骼与骨质疏松专家共识[J].中国骨质疏松杂志, 2016,22(10):1221-1229,1236.
[11] 陈巨鹏,黄桂成,李伟东,等.补肾活血健骨方含药血清对人成骨细胞增殖、分化及矿化功能的影响[J].南京中医药大学学报,2016, 32(6):561-565.
[12] 王吉利,张志海,黄宏兴,等,Bcl2促进UMR-106细胞BMP-2、OPG表达及补肾健脾活血方对其影响[J].中国骨质疏松杂志,2018, 24(7):841-846.
[13] 万雷,黄宏兴,黄红,等.补肾健脾活血方含药血清提高过表达 Sost 转染成骨细胞增殖和碱性磷酸酶活性[J]. 中国组织工程研究, 2018,22(16):2461-2466.
[14] 万雷,黄宏兴,张志海,等.补肾健脾活血方干预沉默 DKK1、Sost 骨细胞对细胞活性和相关蛋白的影响研究[J].中国骨质疏松杂志, 2018,24(8):989-993,1007.
[15] 柴生颋,谢平金,万雷,等.补肾健脾活血方含药血清对 UMR106 细胞成骨分化和骨形成相关蛋白的影响[J]. 中国骨质疏松杂志, 2018,24(3):361-365.
[16] Feng J, Liu S, Ma S, et al.Protective effects of resvera-trol on postmenopausal osteoporosis: regulation of SIRT1-NF-kappa B signaling pathway. Acta Biochim Biophys Sin (Shanghai). 2014;46:1024-1033.
[17] 王艳梅,木合塔尔·霍加,张晨.转化生长因子β及其信号通路的研究进展[J].医学综述,2011,17(22):3367-3369.
[18] 王凯,宋敏.转化生长因子-β在骨代谢中作用机制的研究进展[J].中国骨质疏松杂志,2020,26(2):308-312.
[19] Chen G, Deng C, Li YP.TGF-beta and BMP Signaling in Osteoblast Differentiation and Bone Formation. Int J Biol Scl.2012;8(2):272-288.
[20] Luu HH, Song WX, Luo X, et al. Distinct Roles of Bone Morphogenetic Proteins in Osteogenic Differentiation of Mesenchymal Stem Cells. J Orthop Res. 2007;25(5):665-677.
[21] Abula K, Muneta T, Miyatake K,et al.Elimination of BMP7 From the Developing Limb Mesenchyme Leads to Articular Cartilage Degeneration and Synovial Inflammation with Increased Age. Febs Lett. 2015;589(11):1240-1248.
[22] Styrkarsdottir U, Cazier JB, Kong A, et al. Linkage of Osteoporosis to Chromosome 20P12 and Association to BMP2. Plos Biol. 2003;1(3):E69.
[23] 施彦龙,李应福. BMP /Smads、OPG/RANK/RANKL信号通路与骨质疏松关系的研究进展[J].中国骨质疏松杂志,2020,26(4):600-604.
[24] Dallas SL, Prideaux M, Bonewald LF. The osteocyte:an endocrine cell and more. Endocr Rev. 2013;34: 658-690.
[25] 陈群群,黄宏兴.“肌少-骨质疏松症”的研究现状与进展[J].中国骨质疏松杂志,2018,24(10):1346-1352.
[26] 冯婷婷,王佳贺.骨质疏松与肌少症相关性研究进展[J].实用老年医学,2020,34(3):216-219.
[27] 赵航,马慧娟,王超.骨质疏松症相关基因研究进展[J].实用老年医学,2019,33(6):523-527.
[28] 姜坤,周强,尚德阳,等.补肾活血方对骨质疏松症模型大鼠骨密度及BMP-2蛋白表达影响实验研究[J].辽宁中医药大学学报,2016, 18(5):20-22.
[29] 郭小玲,甘国兴,李劲平,等.壮骨止痛方对去卵巢骨质疏松大鼠血清TGF-β和AKP3的影响[J].中医药导报,2016,22(14):21-23.
[30] 杨丽君,吴永华,张俐.肌少症、骨质疏松症的关系及研究进展[J].中国骨质疏松杂志,2017,23(8):1112-1116.
[31] 许一帆,樊炳楷,黄金山,等.肌少-骨质疏松症的研究进展[J].中医正骨,2019,31(5):22-25.
|